Weekend-free and robotics-compatible protocols for high-throughput human-induced pluripotent stem cell maintenance, amplification, and differentiation
Stem Cells Translational Medicine · 20.07.2026 · 15 (8)
DOI: 10.1093/stcltm/szag060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 06.08.2026. Verfasst von Mariam Jouni und 20 weiteren Autor:innen. Beteiligte Einrichtung: Genomics Research Center, AbbVie, Lake Bluff, IL 60044, United States. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Cell Differentiation, Robotics, Cell Culture Techniques. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS.
Abstract (Originalsprache)
Background
Human induced pluripotent stem cells (hiPSCs) are essential tools for disease modeling, drug testing, and regenerative medicine. These applications require differentiation of multiple cell lines in parallel, synchronized production of large numbers of hiPSCs and differentiated cells, and assessment of differentiation efficiency before proceeding to in-depth characterization through molecular and cellular assays. However, hiPSC culture protocols are often laborious manual processes, which affects reproducibility and makes high-throughput applications challenging.
Methods
We describe high-throughput hiPSC maintenance and amplification protocols that are weekend-free, scalable, and can be performed manually or automated. These optimized protocols enable scale-up of hiPSC production and differentiation to multiple cell types, including endothelial cells, microglia, and retinal pigment epithelial cells.
Results
We characterized the differentiated cells using molecular and cellular assays and demonstrated that cells generated with this approach represent accurate cell identities.
Conclusion
The approaches described here enable high-throughput hiPSC applications and improve reproducibility and scalability.If you want, I can also tighten this further to better fit a strict 350-word journal limit or adapt the heading style to a specific journal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genomics Research Center, AbbVie, Lake Bluff, IL 60044, United States.
- Advanced Cell Technologies and Screening Group, Neuroscience Discovery, AbbVie, Cambridge, MA 02139, United States.
- Neuroscience Discovery, AbbVie Deutschland GmbH & Co KG, Ludwigshafen am Rhein, 67061, Germany.
- Ophthalmology Discovery Research, Abbvie, Irvine, CA, United States.
ORCID-Profile: Mariam Jouni, Emily Y Chen, Alexandra Griffiths
Förderung
- NIH HHS
Zitieren
APA
Jouni, M., Petiwala, S., Desai, D., Gawlak, G., Chen, E. Y., Griffiths, A., Hogan, C., Thomanetz, V. E., Lee, C. H., Tamm, J., Bahnassawy, L., Käfer, E., Finck, A., Bopp, S., Barlan, K., Wambeke, E. L., Verduzco, D., Painter, J. D., Gandhi, J., …, & Den Hollander, A. I. (2026). Weekend-free and robotics-compatible protocols for high-throughput human-induced pluripotent stem cell maintenance, amplification, and differentiation. Stem Cells Translational Medicine, 15(8). https://doi.org/10.1093/stcltm/szag060
Vancouver
Jouni M, Petiwala S, Desai D, Gawlak G, Chen EY, Griffiths A, et al. Weekend-free and robotics-compatible protocols for high-throughput human-induced pluripotent stem cell maintenance, amplification, and differentiation. Stem Cells Translational Medicine. 2026;15(8). doi:10.1093/stcltm/szag060
BibTeX
@article{Jouni2026,
author = {Jouni, Mariam and Petiwala, Sakina and Desai, Divya and Gawlak, Grzegorz and Chen, Emily Y and Griffiths, Alexandra and Hogan, Christopher and Thomanetz, Venus E and Lee, Cecilia Heyne and Tamm, Joseph and Bahnassawy, Lamiaa and Käfer, Elke and Finck, Anja and Bopp, Sabina and Barlan, Kari and Wambeke, Emma L and Verduzco, Daniel and Painter, Jacob D and Gandhi, Jarel and Reinhardt, Peter and Den Hollander, Anneke I},
title = {Weekend-free and robotics-compatible protocols for high-throughput human-induced pluripotent stem cell maintenance, amplification, and differentiation},
journal = {Stem Cells Translational Medicine},
year = {2026},
volume = {15},
number = {8},
doi = {10.1093/stcltm/szag060}
}
EUVIMED